- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 30, 2024 | 54.91M sh |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $197.9M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $71M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $11.07M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $11.55M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $11.07M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $11.55M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $374.52M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $250.94M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $378.81M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $254.67M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $175.53M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $202.3M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 27.94M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $5K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$13.25M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $211.36M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $221.22M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.40 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.40 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $5.46M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$11.19M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$13.49M |